50 Gy Stereotactic Body Radiation Therapy to the Dominant Intra-Prostatic Nodule: Results from a Phase Ia/b Trial
After prostate radiation therapy (RT) local recurrences are observed in the dominant intraprostatic nodule (DIN). This phase Ia/b study safely escalated the RT dose to the DIN up to 50 Gy by using stereotactic body radiation therapy (SBRT) without grade 3 acute toxicity. SBRT increased antigen specific immune responses in a subset of patients
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Fernanda G. Herrera, Massimo Valerio, Dominik Berthold, Thomas Tawadros, Jean-Yves Meuwly, Veronique Vallet, Petra Baumgaertner, Anne-Christine Thierry, Berardino De Bari, Patrice Jichlinski, Lana Kandalaft, George Coukos, Alexandre Harari, J. Bourhis Tags: Clinical Investigation Source Type: research
More News: Biology | Cancer & Oncology | Physics | Radiation Therapy | Radiology | Study | Toxicology